Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, December 28, 2016
Recipharm AB has announced that its Chief Financial Officer (CFO) Björn Westberg has resigned from his position with the company.
read more
Monday, February 26, 2018
Recipharm AB announced that Henrik Stenqvist has resigned from his position with the company to pursue other opportunities.
read more
Chi-Med and BeiGene have entered into a collaboration agreement to evaluate two of Chi-Med’s drug candidates, surufatinib and fruquintinib, with BeiGene’s anti-PD-1 antibody tislelizumab, for solid tumor cancers.
read more
Tuesday, November 07, 2017
Chesapeake IRB and Schulman IRB have combined to create Advarra, the premier provider of IRB, institutional biosafety committee and research compliance services in North America.
read more
Thursday, September 22, 2016
Chesapeake IRB, a provider of independent institutional review board services for the life science industry, has hired Randall Hein, an executive with more than 20 years of experience in operations, sales and consulting for life science organizations...
read more
Chesapeake IRB announced it has acquired MaGil IRB, a central IRB located in Rockville, Md.
read more
Chesapeake IRB announced it has acquired Institutional Biosafety Corporation (IBC), a provider of institutional biosafety committee services located in Rockville, Md.
read more
Wednesday, March 20, 2019
CherryCircle announced the appointment of Emma Cartmell to its board of directors.
read more
Wednesday, August 20, 2025
ChemPartner announced its strategic expansion in the U.S. with the upcoming opening of the ChemPartner Boston Center of Excellence in Watertown, MA. The new R&D site will commence operations on September 10, 2025, providing discovery and preclinical ...
read more
-- 100 Contract Research and Contract Manufacturing Organizations will be exhibiting at this year's September 17-19, 2013 Pharma ChemOutsourcing Show at the Jersey Shore reported Apaporis LLC, the organizer. The companies offer a wide range of ...
read more
Chemomab Therapeutics,Ltd., a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, and AGC Biologics, a global Biopharmaceutical Contract Development ...
read more
Chemic Laboratories Inc. and ASI today announced
establishment of a formal three year Joint Cooperation Agreement that will enable the two firms
to collaborate on a variety of Pharmaceutical and Biopharmaceutical client interests, primarily in
the...
read more
Wednesday, November 15, 2017
ChemDiv has entered into a three-way co-development agreement with Context Therapeutics and Torrey Pines Investment to advance research and development in the area of Sigma1 dysfunction.
read more
Thursday, January 12, 2017
ChemDiv, Inc., a global research organization, announced achieving several key milestones in collaboration with Abbott's branded generics pharmaceutical business. The collaboration, begun in 2012 and expanded in 2015, is aimed at development and ...
read more
ChemConnection, a privately-held company manufacturing nanomedicines, bioconjugates, peptides, and small molecules, announces the successful GMP production of CriPec® docetaxel for its customer Cristal Therapeutics, a privately-held life sciences ...
read more